Skip to content
healthcare.dev

EGRIFTA WR

NDC 62064-381, tesamorelin, kit, from Theratechnologies Inc..

Product NDC
62064-381
Status
Listed
Labeler
Theratechnologies Inc.
Dosage form
KIT
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022505
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62064-381 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
62064-381-04620640381041 KIT in 1 BOX (62064-381-04) * 1.3 mL in 1 VIAL (62064-371-01) * 30 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/839334d3-8c1d-4c26-9036-2ab524a6ea75

Use it

Look up 62064-381 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62064-381 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62064-381. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.